RAPID ALTERATION OF C-MYC AND C-JUN EXPRESSION IN LEUKEMIC-CELLS INDUCED TO DIFFERENTIATE BY A BUTYRIC-ACID PRODRUG

被引:64
作者
RABIZADEH, E
SHAKLAI, M
NUDELMAN, A
EISENBACH, L
REPHAELI, A
机构
[1] BASIL & GERALD FELSENSTEIN MED RES CTR,BEILINSON CAMPUS,IL-49100 PETAH TIQWA,ISRAEL
[2] BAR ILAN UNIV,DEPT CHEM,IL-52910 RAMAT GAN,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[4] WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL
[5] HEMATOL INST,IL-49100 PETAH TIQWA,ISRAEL
关键词
C-MYC; C-JUN; BUTYRIC ACID; BUTYRIC ACID PRODRUG; PROLIFERATION; DIFFERENTIATION;
D O I
10.1016/0014-5793(93)80932-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The novel prodrug of butyric acid (BA), pivaloyloxymethyl butyrate, has been shown, in vitro, to induce differentiation and inhibit leukemic cell proliferation. The prodrug affects the cells in vitro at lower concentration and at least 100 times faster than does (BA). We have compared the ability of BA with that of its prodrug AN-9 to modulate the expression of the early regulating genes, c-myc and c-jun, in HL-60 cells. Exposure of HL-60 cells to the prodrug resulted in a decrease of c-myc and an increase of c-jun expression. The prodrug elicited this effect at lower concentrations and at least 100 times faster than BA. Since changes in the expression of c-myc and c-jun occur minutes after exposure of the cells to the prodrug, these genes are likely to play a major role in the early stages of the differentiation pathway.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 20 条
[1]   ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1 [J].
ANGEL, P ;
ALLEGRETTO, EA ;
OKINO, ST ;
HATTORI, K ;
BOYLE, WJ ;
HUNTER, T ;
KARIN, M .
NATURE, 1988, 332 (6160) :166-171
[2]   C-FOS AND C-JUN PROTOONCOGENE EXPRESSION IS DECREASED IN PSORIASIS - AN INSITU QUANTITATIVE-ANALYSIS [J].
BASSETSEGUIN, N ;
ESCOT, C ;
MOLES, JP ;
BLANCHARD, JM ;
KERAI, C ;
GUILHOU, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (04) :672-678
[3]   THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA [J].
BATTEY, J ;
MOULDING, C ;
TAUB, R ;
MURPHY, W ;
STEWART, T ;
POTTER, H ;
LENOIR, G ;
LEDER, P .
CELL, 1983, 34 (03) :779-787
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   THE MYC ONCOGENE - ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION [J].
COLE, MD .
ANNUAL REVIEW OF GENETICS, 1986, 20 :361-384
[6]   AMPLIFICATION OF ENDOGENOUS MYC-RELATED DNA-SEQUENCES IN A HUMAN MYELOID-LEUKEMIA CELL-LINE [J].
COLLINS, S ;
GROUDINE, M .
NATURE, 1982, 298 (5875) :679-681
[7]  
GROSSO LE, 1985, CANCER RES, V45, P847
[8]  
HSU SM, 1972, AM J PATHOL, V140, P155
[9]  
KOEFFLER HP, 1983, BLOOD, V62, P709
[10]   TRANSFECTION OF MOUSE ERYTHROLEUKEMIA-CELLS WITH MYC SEQUENCES CHANGES THE RATE OF INDUCED COMMITMENT TO DIFFERENTIATE [J].
LACHMAN, HM ;
CHENG, GH ;
SKOULTCHI, AI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (17) :6480-6484